You are here

COVID-19

Three doses of mRNA COVID vaccine show advantage against severe outcomes --study

A team led by US Food and Drug Administration (FDA) researchers studying Medicare claims data during the early Omicron SARS-CoV-2 variant months conclude that a third dose of mRNA COVID-19 vaccine provides significant protection against hospitalization and death compared with two doses but wanes substantially after 4 months.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to COVID-19
howdy folks
Page loaded in 1.388 seconds.